Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
Abstract Background Specific clinical risk factors may contribute to improving or worsening neurological functions in acute ischemic stroke (AIS) patients pre-treated with a combined cholesterol reducer and recombinant tissue plasminogen activator (rtPA) therapy. In this study, clinical risk factors...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2020-05-01
|
| Col·lecció: | Lipids in Health and Disease |
| Matèries: | |
| Accés en línia: | http://link.springer.com/article/10.1186/s12944-020-01270-2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|